RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer

Violeta Serra; Pieter J.A. Eichhorn; Celina García-García; Yasir H. Ibrahim; Ludmila Prudkin; Gertrudis Sánchez; Olga Rodríguez; Pilar Antón; Josep-Lluís Parra; Sara Marlow; Maurizio Scaltriti; José Pérez-Garcia; Aleix Prat; Joaquín Arribas; William C. Hahn; So Young Kim; José Baselga

首页> 外文期刊>The journal of clinical investigation >RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer

【24h】

RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer

机译：RSK3 / 4介导乳腺癌对PI3K途径抑制剂的耐药性

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Original citation: J. Clin. Invest. 2013;123(6):25512563.doi:10.1172/JCI66343.Citation for this corrigendum: J. Clin. Invest. 2014;124(3):1418.doi:10.1172/JCI75534.

机译：原始引用：J. Clin。投资。 2013; 123（6）：25512563.doi：10.1172 / JCI66343。本勘误的引文：J.Clin。投资。 2014; 124（3）：1418.doi：10.1172 / JCI75534。

著录项

来源
《The journal of clinical investigation》 |2014年第3期|共1页
作者
Violeta Serra; Pieter J.A. Eichhorn; Celina García-García; Yasir H. Ibrahim; Ludmila Prudkin; Gertrudis Sánchez; Olga Rodríguez; Pilar Antón; Josep-Lluís Parra; Sara Marlow; Maurizio Scaltriti; José Pérez-Garcia; Aleix Prat; Joaquín Arribas; William C. Hahn; So Young Kim; José Baselga;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer [J] . Violeta Serra, Pieter J.A. Eichhorn, Celina García-García, The journal of clinical investigation . 2013,第6期

机译：RSK3 / 4介导乳腺癌对PI3K途径抑制剂的耐药性
2. A combination of the PI3K pathway inhibitor plus cell cycle pathway inhibitor to combat endocrine resistance in hormone receptor-positive breast cancer: a genomic algorithm-based treatment approach [J] . Anita Gul, Brain Leyland-Jones, Nandini Dey, American Journal of Cancer Research . 2018,第12期

机译：PI3K途径抑制剂与细胞周期途径抑制剂的组合可对抗激素受体阳性乳腺癌的内分泌抵抗：一种基于基因组算法的治疗方法
3. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclearn factor-kappa B signaling pathways in MCF7 breast cancer cells [J] . Zhimin He Acta Biochimica et Biophysica Sinica . 2011,第8期

机译：乳腺癌抗性蛋白的上调通过MCF7乳腺癌细胞中的PI3K / Akt和核因子-κB信号通路在HER2介导的化学抗性中起作用
4. Label-free phosphoproteomics method to investigate signaling pathways downstream of novel PI3K/mTOR inhibitors in cancer cells [C] . Pedro Casado, Juan Carlos Rodriguez-Prados, Sabina Cosulich, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：无标记的磷蛋白质方法，用于研究新型PI3K / MTOR抑制剂在癌细胞中的信号通路
5. Targeting the MEK5, MEK1/2, and/or Pi3k Pathways Reverses Epithelial to Mesenchymal Transition and Enhances Chemotherapeutic Sensitivity in Breast and Brain Cancers with a Mesenchymal Phenotype [D] . Bhatt, Akshita B. 2021

机译：靶向MEK5，MEK1 / 2和/或PI3K途径将上皮细胞转型的上皮性反转，并通过间充质表型提高乳腺癌和脑癌中的化疗敏感性
6. RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer [O] . Violeta Serra, Pieter J.A. Eichhorn, Celina García-García, 2014

机译：RSK3 / 4介导乳腺癌对PI3K途径抑制剂的耐药性
7. RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer [O] . Violeta Serra, Pieter J.A. Eichhorn, Celina García-García, 2014

机译：RSK3 / 4在乳腺癌中介导对PI3K途径抑制剂的抗性

RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅